CN104171137A - Blood pressure-reducing and lipid-lowering tea - Google Patents
Blood pressure-reducing and lipid-lowering tea Download PDFInfo
- Publication number
- CN104171137A CN104171137A CN201410397672.0A CN201410397672A CN104171137A CN 104171137 A CN104171137 A CN 104171137A CN 201410397672 A CN201410397672 A CN 201410397672A CN 104171137 A CN104171137 A CN 104171137A
- Authority
- CN
- China
- Prior art keywords
- tea
- reducing
- blood pressure
- gynostemma pentaphylla
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention provides blood pressure-reducing and lipid-lowering tea. Raw materials of the tea comprise gynostemma pentaphylla, apocynum venetum and cooked Pu'er tea. Compared with the traditional gynostemma pentaphylla tea, apocynum venetum tea or mixed tea of gynostemma pentaphylla and apocynum venetum, the blood pressure-reducing and lipid-lowering tea disclosed by the invention has more intensive effects of reducing blood pressure and lowering lipid, the raw material apocynum venetum has the effect of reducing blood pressure, the gynostemma pentaphylla has the effects of improving the immunity of the organism and resisting cancers; the cooked Pu'er tea has the effect of lowering lipid, the three raw materials supplement one another and can overcome side effects of one another, and the pharmacological actions can be improved, so that the effects of effectively reducing blood pressure, lowering lipid and reducing the side effects are achieved, and the blood pressure-reducing and lipid-lowering tea is mellow in taste and suitable for being drunk for a long time.
Description
Technical field
The present invention relates to a kind of tea, particularly a kind of tea for reducing hypertension and fat.
Background technology
The hypertension, hyperlipemia incidence of disease is high, is middle-aged and old common diseases, and patient often drinks some tea that are beneficial to hypertension and hyperlipemia except will adhering to medicine treatment can play good auxiliary therapeutic action.The total class of hypertension and hyperlipemia medicinal herb tea is in the market various, is mainly that gynostemma pentaphylla tea, dogbane tea or the two mixing are made tea.But gynostemma pentaphylla and bluish dogbane lipid-reducing function are poor, its validity is under suspicion.Traditional Chinese medicine is thought gynostemma pentaphylla and bluish dogbane bitter, cold in nature, and use can make side effect strengthen together.The two tea bubbling out is faintly acid, and intestines and stomach are had to excitant, long-term use can cause gastrointestinal function infringement and hepatic and renal function bad, and tea mouthfeel is extremely puckery, is unfavorable for long-term taking.
Summary of the invention
In view of this, the invention provides that a kind of hypertension and hyperlipemia is respond well, mouthfeel is mellow, be applicable to the tea for reducing hypertension and fat of long-term taking.
A kind of tea for reducing hypertension and fat, the raw material of this tea for reducing hypertension and fat comprises gynostemma pentaphylla, bluish dogbane, ripe Pu'er tea.
The beneficial effect of tea for reducing hypertension and fat provided by the invention is: raw material bluish dogbane has the effect of reducing blood pressure, gynostemma pentaphylla has the immunity of organisms of raising and anticancer effect, ripe Pu'er tea has the effect that reduces blood fat, and three kinds of raw materials complement each other, can overcome mutually side effect, improve pharmacological action each other simultaneously, thereby reach effective hypertension and hyperlipemia, reduce the effect of side effect, and mouthfeel is mellow, is applicable to long-term taking.
Detailed description of the invention
The invention provides a kind of tea for reducing hypertension and fat, its raw material comprises gynostemma pentaphylla, bluish dogbane, ripe Pu'er tea.Preferably, the percentage by weight of each raw material is ripe Pu'er tea 30% ~ 70%, gynostemma pentaphylla 10% ~ 50%, bluish dogbane 5% ~ 20%.The data analysis obtaining through research staff's great many of experiments, according to the above ratio to ripe Pu'er tea, the optimization of the proportioning of gynostemma pentaphylla and bluish dogbane, can make the curative effect of tea for reducing hypertension and fat reach best, and mouthfeel the best.
Below in conjunction with embodiment, tea for reducing hypertension and fat provided by the invention is further described.
Embodiment 1
The present embodiment provides a kind of tea for reducing hypertension and fat, taking gynostemma pentaphylla, bluish dogbane, ripe Pu'er tea as raw material, by weight ratio by 65 parts of ripe Pu'er teas, 20 parts of gynostemma pentaphylla, 15 parts of clean dry of bluish dogbane, mix, be distributed in outer packaging bag, after vacuum seal, get product.
Embodiment 2
The present embodiment provides a kind of tea for reducing hypertension and fat, taking gynostemma pentaphylla, bluish dogbane, ripe Pu'er tea as raw material, by weight ratio by 57.5 parts of ripe Pu'er teas, 45 parts of gynostemma pentaphylla, 12.5 parts of clean dry of bluish dogbane, mix, be distributed in outer packaging bag, after vacuum seal, get product.
Embodiment 3
The present embodiment provides a kind of tea for reducing hypertension and fat, taking gynostemma pentaphylla, bluish dogbane, ripe Pu'er tea as raw material, by weight ratio by 50 parts of ripe Pu'er teas, 40 parts of gynostemma pentaphylla, 10 parts of clean dry of bluish dogbane, mix, be distributed in outer packaging bag, after vacuum seal, get product.
In above embodiment, three kinds of raw materials all have pharmacological action, as reduce blood pressure and reduce blood fat.
Bluish dogbane has the effect of removing vascular wall deposit, softening blood vessel, step-down fat eliminating, voltage stabilizing throughout the year.Bluish dogbane contains tannin, can keep or recover the normal resistance of capillary, strengthens pliability and the elasticity of blood vessel, can reduce serum cholesterol, prevents that fat from depositing in vascular wall.Tannic acid in tealeaves can suppress blood pressure and raise, and reduces hyperpietic's blood pressure.Particularly dogbane tea has good decomposition to protein and fat.Tea Polyphenols and vitamin C can reduce cholesterol and blood fat.
It is gynosaponin, gynostemma pentaphylla glucoside that gynostemma pentaphylla mainly contains effective constituent, and topmost effect is immunity, anti-curing oncoma and the slight reduction blood fat that increases human body.
In ripe Pu'er tea, there is monascus ruber.Monascus ruber mainly contains three effects greatly: 1, suppress harmful bacteria growth; 2, the effect of reducing blood pressure; 3, there is reduction blood fat.In the Pu'er tea of monascus ruber fermentation, can isolate Lovastatin, Simvastatin class material, and statin substance have highly significant reduction T-CHOL, reduce LDL-C, reduce serum triglyceride, reduce the comprehensive therapeutic effect of AI, increasing high density lipoprotein cholesterol, and can effectively treat the cardiovascular and cerebrovascular disease such as coronary heart disease, headstroke and the disease relevant to high fat of blood, as diabetes, nephrotic syndrome and fatty liver, it is current the most effective universally acknowledged lipopenicillinase material.
Above three kinds of Chinese medicines all have similar pharmacological action, as reduce blood pressure and reduce blood fat.But emphasis difference: 1, bluish dogbane is mainly to possess the effect of reducing blood pressure; 2, gynostemma pentaphylla is mainly to improve the immunity of body and the effect of pre-preventing tumor; 3, ripe Pu'er tea is mainly to reduce blood fat.
All there is side effect in three kinds of raw materials, as take bluish dogbane and may produce nervous system toxicity and renal toxicity, take gynostemma pentaphylla and may have renal toxicity and digestive system toxicity, and ripe Pu'er tea in process of production, when producing monascus ruber, likely produce the harmful substances such as Aspergillus flavus, but three kinds of raw materials fit over together, can overcome mutually side effect, can improve pharmacological action each other simultaneously.
Tradition tea for reducing hypertension and fat is mainly that gynostemma pentaphylla tea, dogbane tea or the two mixing are made tea, but its lipid-reducing function is poor, only have the consumption of increasing just can make fat-reducing effect be promoted, but after strengthening consumption, toxic and side effect is large.In the ripe Pu'er tea of monascus ruber fermentation, can isolate Lovastatin, Simvastatin class Hypolipidemic substance, the red colouring agent for food, also used as a Chinese medicine that simultaneously has monascus ruber to produce in ripe Pu'er tea have the effect of reducing blood pressure, so add after ripe Pu'er tea, can make the blood fat-reducing blood pressure-decreasing function of formula all obviously increase.
From traditional Chinese medical science angle, gynostemma pentaphylla, bluish dogbane are cold in nature, bitter, and two kinds of cold things use together, can make side effect strengthen, and ripe Pu'er tea are warm in nature, taste is sweet, and three kinds of raw materials use can neutralization cold together, thereby reduce side effect.
From doctor trained in Western medicine angle, the tea that gynostemma pentaphylla, bluish dogbane bubble out is faintly acid, intestines and stomach are had to excitant, long-term use can cause gastrointestinal function infringement and hepatic and renal function bad, and the tea that the ripe tea of Pu'er tea bubbles out is alkalescent, acid-base neutralization can alleviate digestive system side effect, can alleviate liver renal toxicity and nervous system toxicity that bluish dogbane and gynostemma pentaphylla bring.
Ripe Pu'er tea during the fermentation, when producing monascus ruber, likely produces the harmful substances such as Aspergillus flavus, and gynostemma pentaphylla is improved immunity for human body, pre-preventing tumor, the possibility of preventing may exist in Pu'er tea harmful bacteria induced tumor.
From the mouthfeel of tea, the tea mouthfeel that gynostemma pentaphylla, bluish dogbane bubble out is extremely puckery, allows people be difficult to long-term taking, and ripe Pu'er tea taste and sweet mouthfeel, mellow has unique fat fragrance, can gland gynostemma pentaphylla, the bitterness of bluish dogbane, effectively improve the mouthfeel of tea, make people more acceptant.
In sum, three kinds of raw materials complement each other, and can overcome mutually side effect, improve pharmacological action each other simultaneously, thereby reach effective hypertension and hyperlipemia, reduce the effect of side effect, and mouthfeel are mellow, are applicable to long-term taking.
The foregoing is only preferred embodiment of the present invention, in order to limit the present invention, within the spirit and principles in the present invention not all, any amendment of doing, be equal to replacement, improvement etc., within all should being included in protection scope of the present invention.
Claims (5)
1. a tea for reducing hypertension and fat, is characterized in that: the raw material of this tea for reducing hypertension and fat comprises bluish dogbane, gynostemma pentaphylla, ripe Pu'er tea.
2. tea for reducing hypertension and fat as claimed in claim 1, is characterized in that: the percentage by weight of described raw material is ripe Pu'er tea 30% ~ 70%, gynostemma pentaphylla 10% ~ 50%, bluish dogbane 5% ~ 20%.
3. tea for reducing hypertension and fat as claimed in claim 2, is characterized in that: the percentage by weight of described raw material is ripe Pu'er tea 65%, gynostemma pentaphylla 20%, bluish dogbane 15%.
4. tea for reducing hypertension and fat as claimed in claim 2, is characterized in that: the percentage by weight of described raw material is ripe Pu'er tea 57.5%, gynostemma pentaphylla 30%, bluish dogbane 12.5%.
5. tea for reducing hypertension and fat as claimed in claim 2, is characterized in that: the percentage by weight of described raw material is ripe Pu'er tea 50%, gynostemma pentaphylla 40%, bluish dogbane 10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410397672.0A CN104171137B (en) | 2014-08-14 | 2014-08-14 | Tea for reducing hypertension and fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410397672.0A CN104171137B (en) | 2014-08-14 | 2014-08-14 | Tea for reducing hypertension and fat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104171137A true CN104171137A (en) | 2014-12-03 |
| CN104171137B CN104171137B (en) | 2015-08-19 |
Family
ID=51952706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410397672.0A Expired - Fee Related CN104171137B (en) | 2014-08-14 | 2014-08-14 | Tea for reducing hypertension and fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104171137B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104904907A (en) * | 2015-06-03 | 2015-09-16 | 杨胜 | Blood-pressure-lowering and blood-liquid-reducing tea |
| CN106692667A (en) * | 2016-11-17 | 2017-05-24 | 中国人民解放军第二军医大学第二附属医院 | Composition with effects of reducing blood pressure, blood fat and blood glucose and use of composition |
| CN107996765A (en) * | 2018-01-04 | 2018-05-08 | 桐乡市春发菊业有限公司 | A kind of general tea of bluish dogbane and its manufacture craft |
| CN108208241A (en) * | 2018-02-22 | 2018-06-29 | 黄月英 | A kind of tea for reducing blood fat and blood pressure |
| CN109730174A (en) * | 2019-01-30 | 2019-05-10 | 刘本德 | A kind of tea for reducing hypertension and fat |
| CN112426448A (en) * | 2020-12-31 | 2021-03-02 | 刘金龙 | Preparation method of health tea |
| CN114532426A (en) * | 2022-03-10 | 2022-05-27 | 石家庄市中医院 | Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102113582A (en) * | 2011-02-24 | 2011-07-06 | 胡三齐 | Jiuwei pressure lowering tea |
| CN102823672A (en) * | 2012-09-13 | 2012-12-19 | 北京师范大学 | Puerh tea compound for controlling blood lipid |
-
2014
- 2014-08-14 CN CN201410397672.0A patent/CN104171137B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102113582A (en) * | 2011-02-24 | 2011-07-06 | 胡三齐 | Jiuwei pressure lowering tea |
| CN102823672A (en) * | 2012-09-13 | 2012-12-19 | 北京师范大学 | Puerh tea compound for controlling blood lipid |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104904907A (en) * | 2015-06-03 | 2015-09-16 | 杨胜 | Blood-pressure-lowering and blood-liquid-reducing tea |
| CN106692667A (en) * | 2016-11-17 | 2017-05-24 | 中国人民解放军第二军医大学第二附属医院 | Composition with effects of reducing blood pressure, blood fat and blood glucose and use of composition |
| CN107996765A (en) * | 2018-01-04 | 2018-05-08 | 桐乡市春发菊业有限公司 | A kind of general tea of bluish dogbane and its manufacture craft |
| CN108208241A (en) * | 2018-02-22 | 2018-06-29 | 黄月英 | A kind of tea for reducing blood fat and blood pressure |
| CN109730174A (en) * | 2019-01-30 | 2019-05-10 | 刘本德 | A kind of tea for reducing hypertension and fat |
| CN112426448A (en) * | 2020-12-31 | 2021-03-02 | 刘金龙 | Preparation method of health tea |
| CN114532426A (en) * | 2022-03-10 | 2022-05-27 | 石家庄市中医院 | Herbal lotus lipid-lowering weight-reducing tea and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104171137B (en) | 2015-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104171137B (en) | Tea for reducing hypertension and fat | |
| Dutta et al. | Kombucha drink: Production, quality, and safety aspects | |
| CN102669331B (en) | Pimpinella diversifolia healthcare tea | |
| CN103211256B (en) | Apple vinegar health care beverage for reducing blood fat and preparation method thereof | |
| CN104621289A (en) | Health promotion-based anti-fatigue and immunity-enhancement pure natural functional drink | |
| CN102134549B (en) | Maitake wine and preparation method thereof | |
| CN101831369B (en) | Golden fungus gingko yellow wine, preparation method and efficacy thereof | |
| CN104382164A (en) | Beverage prepared from lucid ganoderma and black tea fungus | |
| CN107904103A (en) | A kind of dendrobium candidum health liquor and its preparation method and application | |
| CN105451577A (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
| CN104382152A (en) | Method for preparing compound juice drink through two-time fermentation | |
| CN105410240A (en) | Inonotus obliquus health tea and production method thereof | |
| CN104939237A (en) | Chinese yew enzyme beverage and preparation method thereof | |
| CN105360839B (en) | Sweet orange acid Chinese quince beverage and preparation method thereof | |
| CN103109944A (en) | Healthcare tea bagged in teabag and method for preparing same | |
| CN105029553A (en) | Fruit juice-egg-calcium traditional Chinese medicine health beverage and preparation method thereof | |
| CN103110152A (en) | Method for preparing healthcare beverage | |
| CN104450470B (en) | A kind of three-bristle cudrania fruit health liquor and preparation method thereof | |
| CN104872773A (en) | Functional beverage capable of preventing and treating cold and cough | |
| CN104738775A (en) | Plant beverage and preparation technology thereof | |
| US20100247670A1 (en) | Red Grape Dry Composition and Health Tea | |
| CN102987005A (en) | Tea drink suitable for being drunk by people with diabetes | |
| CN106318812A (en) | Healthcare wine and preparation method thereof | |
| CN1287816C (en) | Chinese patent medicine for treating senile dementia and its prearing process | |
| CN105077263B (en) | A kind of medicine-food two-purpose sea cucumber peptide combinations, preparation method and applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150819 Termination date: 20170814 |